✦ LIBER ✦

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

✍ Scribed by Loukas F Kontovinis; Konstantinos T Papazisis; Panagiota Touplikioti; Charalambos Andreadis; Despoina Mouratidou; Alexandros H Kortsaris

Book ID: 115011818
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 278 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-82

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Outcomes for Patients with Meta

Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules

✍ Atkinson, Bradley J.; Kalra, Sarathi; Wang, Xuemei; Bathala, Tharakeswara; Corn, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 569 KB

968 Pharmacogenetic Predictors for Treat

968 Pharmacogenetic Predictors for Treatment Outcome of Sunitinib in Metastatic Renal Cell Carcinoma Patients

✍ H.S. Park; H. Kim; H. Park; W. Kwon; J. Lee; M. Lee; H. Kim; S. Shin; J. Ahn; S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Sequential treatment with sorafenib and

Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study

✍ Loukas Kontovinis, Konstantinos Laschos, Alexandra Karadimou, Charalambos Andrea 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 239 KB

Sarcomatoid Renal Cell Carcinoma: Clinic

Sarcomatoid Renal Cell Carcinoma: Clinical Outcome and Survival After Treatment With Sunitinib

✍ Kunene, Victoria; Miscoria, Manuela; Pirrie, Sarah; Islam, Mohammad R.; Afshar, 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 211 KB

Prognostic nomogram for sunitinib in pat

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi

Association of VEGF and VEGFR2 single nu

Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib

✍ Jenny J. Kim; Susan A.J. Vaziri; Brian I. Rini; Paul Elson; Jorge A. Garcia; Rob 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 954 KB